Precision oncology move to put Amaravati on India's genomics map

In Short

An MoU was signed between the Health Department and AstraZeneca India in the presence of Chief Minister N Chandrababu Naidu

Chief Minister N Chandrababu Naidu at a meeting with AstraZeneca India Managing Director A Praveen Rao, representatives of Strand Life Sciences and Qure.ai after signing of an MoU between AP Health Department and AstraZeneca India
X

Chief Minister N Chandrababu Naidu at a meeting with AstraZeneca India Managing Director A Praveen Rao, representatives of Strand Life Sciences and Qure.ai after signing of an MoU between AP Health Department and AstraZeneca India

Font size
FOLLOW ON Google News

Amaravati: Andhra Pradesh has taken a significant step towards next-generation cancer care, with global biopharmaceutical company AstraZeneca India partnering with the state government to establish an Integrated Genomics Solutions Center in Amaravati, paving the way for India's first integrated precision oncology initiative.

An MoU was signed between the Health Department and AstraZeneca India in the presence of Chief Minister N Chandrababu Naidu. The project will be implemented in collaboration with Strand Life Sciences (part of Reliance) and Qure.ai, integrating genomics, artificial intelligence and advanced diagnostics to deliver personalised cancer treatment.

The initiative will initially focus on lung and breast cancer by enabling advanced genetic and biomarker testing. Using next-generation sequencing (NGS), AI and precision medicine and doctors will be able to identify genetic variations associated with cancer and tailor treatments to individual patients, improving outcomes through early diagnosis and targeted therapies. As part of the programme, AI-powered chest X-ray systems will be deployed in government hospitals to facilitate early detection of lung cancer, enabling faster screening, diagnosis and timely treatment. The precision oncology initiative will be developed through a partnership between Amaravati Quantum Valley and AstraZeneca India, positioning the emerging technology hub as a centre for advanced healthcare research and innovation. Speaking on the occasion, Chief Minister said the partnership aims to make world-class cancer care and advanced medical technologies accessible to the common people. Stressing the growing burden of cancer due to environmental and lifestyle factors, he said healthcare systems should increasingly focus on predictive, preventive and personalised treatment rather than conventional approaches alone.

The Chief Minister also underlined the importance of expanding quantum research into pharmaceuticals, biotechnology and healthcare. Referring to the State’s Sanjeevani initiative, he said Andhra Pradesh is creating digital health records for every citizen, providing a strong foundation for data-driven healthcare and precision medicine. He called for Amaravati Quantum Valley to become a major research hub not only for cancer but also for other critical diseases by bringing together genomics, artificial intelligence and advanced medical research. Chief Secretary G Sai Prasad, AstraZeneca India managing director A Praveen Rao, representatives of Strand Life Sciences and Qure.ai, and senior Health department officials were present at the signing ceremony.

The Hans India
ABOUT THE AUTHOR

The Hans India

Next Story
Share it